Assessing the burden of HPV-related cancers in Appalachia

scientific article published on 10 November 2012

Assessing the burden of HPV-related cancers in Appalachia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4161/HV.22389
P932PMC publication ID3667951
P698PubMed publication ID23143774
P5875ResearchGate publication ID233395956

P50authorElectra D PaskettQ88226762
P2093author name stringThomas C Tucker
James L Fisher
Paul L Reiter
Jesse J Plascak
Alana G Hudson
P2860cites workHuman Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic ReviewQ22306450
Cancer statistics, 2012Q27860574
FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)Q28283721
Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: a cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project.Q33620692
Meta-analysis of Human Papillomavirus Infection ConcordanceQ34293114
Prevalence of HPV infection among men: A systematic review of the literature.Q34567930
U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortalityQ34756890
HPV vaccine and adolescent malesQ35126885
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort studyQ35596225
Risky behaviors among Ohio Appalachian adults.Q35605385
Ohio Appalachia public health department personnel: human papillomavirus (HPV) vaccine availability, and acceptance and concerns among parents of male and female adolescents.Q36374237
Chapter 2: The burden of HPV-related cancersQ36584354
Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian statesQ37210279
Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio AppalachiaQ37236967
HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and womenQ37315939
Cancer incidence in Kentucky, Pennsylvania, and West Virginia: disparities in Appalachia.Q39705932
Cancer in Appalachia, 2001-2003.Q39821137
Variability of cervical cancer rates across 5 Appalachian states, 1998-2003.Q39861135
Prevalence of oral HPV infection in the United States, 2009-2010.Q43794722
Beyond cervical cancer: burden of other HPV-related cancers among men and womenQ44737179
Youth risk behavior surveillance--United States, 2003.Q44902425
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006.Q45251131
Human papillomavirus-associated cancers - United States, 2004-2008.Q45899597
National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.Q47208176
Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States).Q53384848
On Judging the Significance of Differences by Examining the Overlap Between Confidence IntervalsQ58161396
Human papillomavirus vaccine: knowledge and attitudes in two Appalachian Kentucky countiesQ61439941
Breast and cervical cancer screening among Appalachian womenQ64128543
Efficient interval estimation for age-adjusted cancer ratesQ79683204
Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011Q83096756
Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSSQ83689846
P4510describes a project that usesArcGISQ513297
P433issue1
P921main subjectAppalachiaQ2673740
P304page(s)90-96
P577publication date2012-11-10
P1433published inHuman Vaccines & ImmunotherapeuticsQ21072749
P1476titleAssessing the burden of HPV-related cancers in Appalachia
P478volume9

Reverse relations

cites work (P2860)
Q36580570A Community-Academic Partnership to Increase Pap Testing in Appalachian Kentucky
Q37704809Acceptability of HPV vaccine for males and preferences for future education programs among Appalachian residents.
Q90482235Assessing Knowledge Sharing in Cancer Screening Among High-, Middle-, and Low-Income Countries: Insights From the International Cancer Screening Network
Q36995125Correlates of HPV vaccination among adolescent females from Appalachia and reasons why their parents do not intend to vaccinate
Q97568842Disparate survival of late-stage male oropharyngeal cancer in Appalachia
Q30234802Disparity in rates of HPV infection and cervical cancer in underserved US populations.
Q38772035Effects of an Education Intervention about HPV Self-Testing for Healthcare Providers and Staff
Q36580575Fatalistic beliefs and completion of the HPV vaccination series among a sample of young Appalachian Kentucky women
Q34983800HPV prevalence among women from Appalachia: results from the CARE project
Q36456850HPV vaccination among adolescent females from Appalachia: implications for cervical cancer disparities
Q50655601Human papillomavirus vaccine awareness, uptake, and parental and health care provider communication among 11- to 18-year-old adolescents in a rural Appalachian Ohio county in the United States.
Q47110597Need for addressing oral health disparities in rural Appalachia
Q49015051Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home
Q36921646Results of a Multilevel Intervention Trial to Increase Human Papillomavirus (HPV) Vaccine Uptake among Adolescent Girls
Q64135696Results of a Pilot Study of a Mail-Based Human Papillomavirus Self-Testing Program for Underscreened Women From Appalachian Ohio
Q35669149The process of engaging members from two underserved populations in the development of interventions to promote the uptake of the HPV vaccine

Search more.